Forward Therapeutics CEO Toufike Kanouni (L) and CSO Ewan Taylor
Forward Therapeutics, the first biotech from Curie.Bio, raises $50M for oral small molecules in immunology
An 18-month-old Florida biotech has raised a $50 million Series A to wade into the hot immunology and inflammation (I&I) field with oral small molecules …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
